• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化参数对于模型更新和分布自适应重要性的方法。

Methods to Quantify the Importance of Parameters for Model Updating and Distributional Adaptation.

机构信息

Centre for Health Economics, University of York, York, UK.

出版信息

Med Decis Making. 2024 Oct;44(7):802-810. doi: 10.1177/0272989X241262037. Epub 2024 Jul 26.

DOI:10.1177/0272989X241262037
PMID:39056289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11490092/
Abstract

PURPOSE

Decision models are time-consuming to develop; therefore, adapting previously developed models for new purposes may be advantageous. We provide methods to prioritize efforts to 1) update parameter values in existing models and 2) adapt existing models for distributional cost-effectiveness analysis (DCEA).

METHODS

Methods exist to assess the influence of different input parameters on the results of a decision models, including value of information (VOI) and 1-way sensitivity analysis (OWSA). We apply 1) VOI to prioritize searches for additional information to update parameter values and 2) OWSA to prioritize searches for parameters that may vary by socioeconomic characteristics. We highlight the assumptions required and propose metrics that quantify the extent to which parameters in a model have been updated or adapted. We provide R code to quickly carry out the analysis given inputs from a probabilistic sensitivity analysis (PSA) and demonstrate our methods using an oncology case study.

RESULTS

In our case study, updating 2 of 21 probabilistic model parameters addressed 71.5% of the total VOI and updating 3 addressed approximately 100% of the uncertainty. Our proposed approach suggests that these are the 3 parameters that should be prioritized. For model adaptation for DCEA, 46.3% of the total OWSA variation came from a single parameter, while the top 10 input parameters were found to account for more than 95% of the total variation, suggesting efforts should be aimed toward these.

CONCLUSIONS

These methods offer a systematic approach to guide research efforts in updating models with new data or adapting models to undertake DCEA. The case study demonstrated only very small gains from updating more than 3 parameters or adapting more than 10 parameters.

HIGHLIGHTS

It can require considerable analyst time to search for evidence to update a model or to adapt a model to take account of equity concerns.In this article, we provide a quantitative method to prioritze parameters to 1) update existing models to reflect potential new evidence and 2) adapt existing models to estimate distributional outcomes.We define metrics that quantify the extent to which the parameters in a model have been updated or adapted.We provide R code that can quickly rank parameter importance and calculate quality metrics using only the results of a standard probabilistic sensitivity analysis.

摘要

目的

决策模型的开发耗时耗力;因此,将已开发的模型应用于新的目的可能具有优势。我们提供了方法来优先考虑以下两项工作:1)更新现有模型中的参数值,2)使现有模型适应分布成本效益分析(DCEA)。

方法

现有的方法可以评估不同输入参数对决策模型结果的影响,包括信息价值(VOI)和单向敏感性分析(OWSA)。我们应用 1)VOI 来优先搜索额外的信息以更新参数值,2)OWSA 来优先搜索可能因社会经济特征而异的参数。我们强调了所需的假设,并提出了量化模型中参数更新或适应程度的指标。我们提供了 R 代码,可以根据概率敏感性分析(PSA)的输入快速进行分析,并通过肿瘤学案例研究演示了我们的方法。

结果

在我们的案例研究中,更新 21 个概率模型参数中的 2 个,解决了 71.5%的总 VOI,而更新 3 个解决了大约 100%的不确定性。我们提出的方法表明,这是应该优先考虑的 3 个参数。对于 DCEA 的模型适应,总 OWSA 变化的 46.3%来自单个参数,而前 10 个输入参数被发现占总变化的 95%以上,这表明应该针对这些参数进行努力。

结论

这些方法提供了一种系统的方法,可以指导使用新数据更新模型或使模型适应进行 DCEA 的研究工作。案例研究表明,更新超过 3 个参数或适应超过 10 个参数只能带来很小的收益。

重点

搜索证据更新模型或调整模型以考虑公平性问题可能需要分析师大量时间。在本文中,我们提供了一种定量方法来优先考虑参数,以 1)更新现有模型以反映潜在的新证据,2)使现有模型适应估计分布结果。我们定义了量化模型中参数更新或适应程度的指标。我们提供了 R 代码,可以仅使用标准概率敏感性分析的结果快速对参数重要性进行排名并计算质量指标。

相似文献

1
Methods to Quantify the Importance of Parameters for Model Updating and Distributional Adaptation.量化参数对于模型更新和分布自适应重要性的方法。
Med Decis Making. 2024 Oct;44(7):802-810. doi: 10.1177/0272989X241262037. Epub 2024 Jul 26.
2
Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information.成本效益不确定性分析方法:单向敏感性分析、协方差分析和部分完全信息期望值的比较
Med Decis Making. 2015 Jul;35(5):596-607. doi: 10.1177/0272989X14556510. Epub 2014 Oct 27.
3
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.非小细胞肺癌治疗的分布成本效益分析:综合分析及其关键驱动因素的说明。
Pharmacoeconomics. 2023 Aug;41(8):1011-1025. doi: 10.1007/s40273-023-01281-8. Epub 2023 Jun 9.
4
5
When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.多少证据才算足够?——运用系统决策分析和信息价值分析来确定是否需要更多证据。
Z Evid Fortbild Qual Gesundhwes. 2013;107(9-10):575-84. doi: 10.1016/j.zefq.2013.10.020. Epub 2013 Nov 12.
6
Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.使用线性回归元建模从概率敏感性分析计算部分样本信息的期望值。
Med Decis Making. 2015 Jul;35(5):584-95. doi: 10.1177/0272989X15578125. Epub 2015 Apr 3.
7
Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under Uncertainty.加入信息价值衡量指标的净货币效益线以呈现不确定性下经济评估的结果。
Med Decis Making. 2024 Oct;44(7):770-786. doi: 10.1177/0272989X241262343. Epub 2024 Jul 26.
8
Generalisability in economic evaluation studies in healthcare: a review and case studies.医疗保健经济评估研究中的可推广性:综述与案例研究
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.
9
Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.将公平性问题纳入成本效益分析中:系统文献回顾。
Pharmacoeconomics. 2022 Jan;40(1):45-64. doi: 10.1007/s40273-021-01094-7. Epub 2021 Oct 29.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

本文引用的文献

1
An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial.一种用于计算正在进行的试验中生存数据样本信息期望值的有效方法。
Med Decis Making. 2022 Jul;42(5):612-625. doi: 10.1177/0272989X211068019. Epub 2021 Dec 30.
2
Reference Case Methods for Expert Elicitation in Health Care Decision Making.参考案例方法在医疗保健决策中的专家 elicitation。
Med Decis Making. 2022 Feb;42(2):182-193. doi: 10.1177/0272989X211028236. Epub 2021 Jul 16.
3
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models.方法学注释:报告马尔可夫、分区生存和其他非线性模型的确定性与概率结果。
Appl Health Econ Health Policy. 2021 Nov;19(6):789-795. doi: 10.1007/s40258-021-00664-2. Epub 2021 Jul 14.
4
Methods to promote equity in health resource allocation in low- and middle-income countries: an overview.促进中低收入国家卫生资源配置公平性的方法:概述。
Global Health. 2020 Jan 13;16(1):6. doi: 10.1186/s12992-019-0537-z.
5
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit.单向灵敏度分析在概率性成本效果分析中的应用:条件期望增量净收益。
Pharmacoeconomics. 2020 Feb;38(2):135-141. doi: 10.1007/s40273-019-00869-3.
6
Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation.利用专家判断贯穿 NICE 指南制定项目:对当前流程的审查和现有工具对支持专家启发式应用的适用性。
Appl Health Econ Health Policy. 2018 Dec;16(6):819-836. doi: 10.1007/s40258-018-0415-5.
7
A Review of Methods for Analysis of the Expected Value of Information.信息期望价值分析方法综述
Med Decis Making. 2017 Oct;37(7):747-758. doi: 10.1177/0272989X17697692. Epub 2017 Apr 14.
8
How to estimate the health benefits of additional research and changing clinical practice.如何评估额外研究及临床实践变革所带来的健康效益。
BMJ. 2015 Nov 25;351:h5987. doi: 10.1136/bmj.h5987.
9
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.英国国家卫生与临床优化研究所成本效益阈值的估计方法。
Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140.
10
Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information.成本效益不确定性分析方法:单向敏感性分析、协方差分析和部分完全信息期望值的比较
Med Decis Making. 2015 Jul;35(5):596-607. doi: 10.1177/0272989X14556510. Epub 2014 Oct 27.